These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2776832
1. Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF. Franzone JS, Cirillo R, Biffignandi P. Eur J Pharmacol; 1989 Jun 20; 165(2-3):269-77. PubMed ID: 2776832 [Abstract] [Full Text] [Related]
2. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J, Rotilio D, Vargaftig BB. Br J Pharmacol; 1984 Jul 20; 82(3):565-75. PubMed ID: 6430375 [Abstract] [Full Text] [Related]
3. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB. Eur J Pharmacol; 1986 Aug 07; 127(1-2):83-95. PubMed ID: 3019727 [Abstract] [Full Text] [Related]
4. Multiple mechanisms of xanthine actions on airway reactivity. Howell RE. J Pharmacol Exp Ther; 1990 Dec 07; 255(3):1008-14. PubMed ID: 2175791 [Abstract] [Full Text] [Related]
5. New pharmacological data on the bronchospasmolytic activity of bamifylline. Berti F, Magni F, Rossoni G, Schiantarelli P, Bongrani S, Pasargiklian R. Arzneimittelforschung; 1988 Jan 07; 38(1):40-4. PubMed ID: 3365275 [Abstract] [Full Text] [Related]
6. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig. Chignard M, Wal F, Lefort J, Vargaftig BB. Eur J Pharmacol; 1982 Feb 19; 78(1):71-9. PubMed ID: 6804248 [Abstract] [Full Text] [Related]
7. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M, Lefort J, Malanchère E, Vargaftig BB. Eur J Pharmacol; 1987 Aug 21; 140(3):311-21. PubMed ID: 3653247 [Abstract] [Full Text] [Related]
8. Pharmacological profile of 48740 R.P., a PAF-acether antagonist. Lefort J, Sedivy P, Desquand S, Randon J, Coëffier E, Maridonneau-Parini I, Floch A, Benveniste J, Vargaftig BB. Eur J Pharmacol; 1988 Jun 10; 150(3):257-68. PubMed ID: 2843382 [Abstract] [Full Text] [Related]
9. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs. Coëffier E, Borrel MC, Lefort J, Chignard M, Broquet C, Heymans F, Godfroid JJ, Vargaftig BB. Eur J Pharmacol; 1986 Nov 19; 131(2-3):179-88. PubMed ID: 3816952 [Abstract] [Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether). Vargaftig BB, Lefort J, Wal F, Chignard M, Medeiros MC. Eur J Pharmacol; 1982 Aug 27; 82(3-4):121-30. PubMed ID: 7128682 [Abstract] [Full Text] [Related]
11. Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor. Desquand S, Ruffié C, Lefort J, Hatmi M, Pina M, Priego JG, Vargaftig BB. Eur J Pharmacol; 1993 Apr 22; 235(1):101-8. PubMed ID: 7686102 [Abstract] [Full Text] [Related]
12. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. Jancar S, Thériault P, Braquet P, Sirois P. Prostaglandins; 1987 Feb 22; 33(2):199-208. PubMed ID: 3588970 [Abstract] [Full Text] [Related]
13. Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea-pigs. Pretolani M, Lefort J, Leduc D, Vargaftig BB. Br J Pharmacol; 1992 Jul 22; 106(3):677-84. PubMed ID: 1380388 [Abstract] [Full Text] [Related]
14. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F, Touvay C, Lejeune V, Carré C, Vilain B, Broquet C, Mencia-Huerta JM, Braquet P. J Lipid Mediat; 1989 Jul 22; 1(6):329-40. PubMed ID: 2519901 [Abstract] [Full Text] [Related]
15. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Lellouch-Tubiana A, Lefort J, Simon MT, Pfister A, Vargaftig BB. Am Rev Respir Dis; 1988 Apr 22; 137(4):948-54. PubMed ID: 3281530 [Abstract] [Full Text] [Related]
16. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan. Martins MA, Silva PM, Faria Neto HC, Bozza PT, Dias PM, Lima MC, Cordeiro RS, Vargaftig BB. Br J Pharmacol; 1989 Feb 22; 96(2):363-71. PubMed ID: 2924083 [Abstract] [Full Text] [Related]
17. Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. Denjean A, Arnoux B, Benveniste J, Lockhart A, Masse R. Agents Actions; 1981 Dec 22; 11(6-7):567-8. PubMed ID: 7340444 [Abstract] [Full Text] [Related]
18. KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs. Manabe H, Akuta K, Okamura K, Ohmori K. Int Arch Allergy Immunol; 1997 Dec 22; 114(4):389-99. PubMed ID: 9414145 [Abstract] [Full Text] [Related]
19. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs. Pretolani M, Lefort J, Vargaftig BB. Br J Pharmacol; 1989 Jun 22; 97(2):433-42. PubMed ID: 2474345 [Abstract] [Full Text] [Related]
20. Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats. Lima MC, Martins MA, Perez SA, Silva PM, Cordeiro RS, Vargaftig BB. Eur J Pharmacol; 1991 May 17; 197(2-3):201-7. PubMed ID: 1680710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]